Schedule 13G ownership disclosure
DiaMedica Therapeutics Inc
Voting Common Shares, no par value · CUSIP: 25253X207
Event date: 2025-07-23
- Filing-level shares
- 3,110,220
- Percent of class
- 6%
- Cooperman Leon G.
Shares: 3,110,220 · Class: 6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000945621-25-000820
- Form type
- SCHEDULE 13G
- Filer
- COOPERMAN LEON G
- CIK
- CIK 898382
- Filed
- Aug 27, 2025
- Reporting period
- Jul 23, 2025
- Description
- Schedule 13G beneficial ownership